HomeAQST • NASDAQ
add
Aquestive Therapeutics Inc
Previous close
$3.50
Day range
$3.30 - $3.50
Year range
$1.25 - $6.23
Market cap
289.87M USD
Avg Volume
2.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 13.21M | 23.63% |
Operating expense | 12.44M | -22.70% |
Net income | -8.11M | 34.33% |
Net profit margin | -61.42 | 46.88% |
Earnings per share | -0.09 | 60.13% |
EBITDA | -3.42M | 66.33% |
Effective tax rate | -1.26% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 23.87M | -12.47% |
Total assets | 57.42M | 0.61% |
Total liabilities | 163.90M | -6.67% |
Total equity | -106.49M | — |
Shares outstanding | 73.30M | — |
Price to book | -2.26 | — |
Return on assets | -16.73% | — |
Return on capital | 14.92% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.11M | 34.33% |
Cash from operations | -4.94M | -158.72% |
Cash from investing | -16.00K | 38.46% |
Cash from financing | 3.91M | 1,572.22% |
Net change in cash | -1.04M | -112.12% |
Free cash flow | -2.01M | -268.25% |
About
Founded
2004
Headquarters
Website
Employees
135